Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
about
Emerging Roles of Toxin-Antitoxin Modules in Bacterial PathogenesisHow Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Antisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective.Identification and Characterization of msf, a Novel Virulence Factor in Haemophilus influenzae.Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.Why we need a vaccine for non-typeable Haemophilus influenzae.Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.Comparative Genomic Analysis of Haemophilus haemolyticus and Nontypeable Haemophilus influenzae and a New Testing Scheme for Their Discrimination.Immunization with Protein D from Non-Typeable Haemophilus influenzae (NTHi) Induced Cytokine Responses and Bioactive Antibody Production.The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014.Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention.Intercellular adhesion molecule 1 serves as a primary cognate receptor for the Type IV pilus of nontypeable Haemophilus influenzae.Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.Evidence of the presence of nucleic acids and β-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms.Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.New opportunities for managing acute and chronic lung infections.Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.Potential targets for next generation anti-microbial glycoconjugate vaccines.Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014.Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.Structure-based design of chimeric antigens for multivalent protein vaccines.Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzaePneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzaeThe Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
P2860
Q26744373-92519024-C03D-40EA-B0C2-96B317014957Q26748155-96BC91BA-F1B1-4E46-BF7A-932F41E52C6CQ35782062-2F4432AF-EF25-4B5A-9721-BFCCA770E8E7Q35957502-E12C7240-4C4F-4E14-AF1C-2FF0D0103C12Q36555065-D6C28138-935E-4496-91CF-430334613F0FQ37264919-BA0F4C47-6497-47DA-B30D-4B7BB5E69F11Q37396978-59492DCB-43EA-4D72-8D27-53A1CB582656Q37434330-E48014D1-C2EF-48B2-8693-516000B52D24Q37471024-B6FD6712-79BF-408D-92A5-CD2EB8726FB0Q37718996-87D910EB-13D9-4490-87DA-5F2A48D65BE7Q37739619-EC6E1DD1-0A81-4004-9E0E-64BF63160420Q38289742-A813D09E-2E35-4F71-A4F2-DD6818C2D88AQ38646104-E89B9E8E-DCE0-4CE9-99BC-E1CE70A635B9Q38679715-5FBE84A7-EB04-47F9-8DCE-D76C734068C0Q38725448-12852E59-8994-46A6-9066-09BC78A306D7Q40013210-36586BB8-ECDF-496E-B7E7-22311A556B8AQ40235118-723F97BC-6852-4C1E-B9F0-97C73517CD56Q40470161-A045C01D-21EA-4FE4-A1E2-7EC74D08CEEBQ40933342-6DF8C74C-35B3-4C16-B883-1F86BE815C45Q47734944-7ACD7556-EF84-4E04-9320-63534D108B2FQ51411673-3836FE4C-5BAD-497F-9D4A-18535D4A2517Q52349882-F599B4B2-A612-40D4-8EF5-35E60078DDBCQ53701548-922463B2-471A-4ECB-8D7C-E27F949D721CQ55039651-B5F7B2B7-C2D4-42D4-80F9-4E1C7EF43363Q55048565-4F71A58C-69C7-4E84-868E-2FA4C32FB9C6Q55403226-6D7E60B6-DD9C-49A8-BA11-FF453F08B66EQ58101270-307F4308-AF6C-4488-AF5B-D881734B184FQ58798154-66471B78-AF2A-420C-85F2-04BF451CF35BQ59130095-4723E67D-75A4-49AC-97D9-E2363ED8076F
P2860
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@ast
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@en
type
label
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@ast
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@en
prefLabel
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@ast
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@en
P2860
P356
P1476
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
@en
P2860
P304
P356
10.1128/CVI.00089-15
P577
2015-03-18T00:00:00Z